Hims & Hers shares jumped nearly 50% in premarket trade on Monday after a report it has ended a dispute with Novo Nordisk by striking a partnership with the Danish drug giant.
FlashNews:
XORKETS FX to List on NASDAQ Stock Exchange
Huckbros Advances Cinematic Digital Storytelling From Germany’s Black Forest With Ambitious AI Film Initiative
Alphatradfi Unveils Infrastructure Framework to Bridge Traditional Finance and Digital Asset Ecosystems
Breath of Life Recognizes the Emotional and Spiritual Calling of Respiratory Therapists Through a Faith-Centered Reflection Journal
Katherine Wilks Blends Faith, Family, Wellness, and Imagination Across a Diverse Collection of Inspirational and Family-Centered Books
ALPHEA Secures $5M Strategic Funding
SHIBCAT Expands the Robinhood Chain Ecosystem with the Launch of Its Community-Driven Meme Token
Tolicious Secures Growth Investment from Mercia Ventures to Accelerate North East Expansion
ADVAN ADVERTISING INC. (ADVAPP) Agent Network Surpasses 800,000
Paul Krige’s Zebras Explores Music, Friendship, and Moral Choice in Apartheid-Era South Africa
Vietnam RWA Summit 2026 shapes the digital future
THE GENTLING OF HANNA JOHANSEN: A BETRAYAL OF TRUST
A “Breaker of Hearts, or Horses” Head-on Resistance-Breaking or Gentling Techniques in Treating Acute Psychological Trauma during Adolescence
Asprofin Bank and Digital TRVST Forge Banking-as-a-Service Alliance as Embedded Finance Nears $7 Trillion
‘Paraphernalia,’ a Short-Story Collection by Godfrey Bonavia, Now Available
Necronomicon Nursery Rhymes Invites Readers to Meet the Monsters They Were Never Supposed to Like
Educator-Author Kerry Espey Releases Not Yet, a Picture Book to Support Kids Through Big Feelings and Growth
Caiou Launches with the Rise of Korean Dopamine Sites for Gen Z
Prime Lake Capital Review: How Client Assets, Withdrawals, Fees, and Account Controls Work
Home » Hims & Hers stock rockets on reported end to Novo Nordisk weight-loss drug dispute